These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 15660048)

  • 41. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.
    Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
    Am J Cardiol; 2007 Aug; 100(4):690-6. PubMed ID: 17697830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of metoprolol on cytokine levels in chronic heart failure--a substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF).
    Gullestad L; Ueland T; Brunsvig A; Kjekshus J; Simonsen S; Frøland SS; Aukrust P
    Am Heart J; 2001 Mar; 141(3):418-21. PubMed ID: 11231439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]).
    de Boer RA; Doehner W; van der Horst IC; Anker SD; Babalis D; Roughton M; Coats AJ; Flather MD; van Veldhuisen DJ;
    Am J Cardiol; 2010 Jul; 106(1):78-86.e1. PubMed ID: 20609652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival and hospitalization in heart failure patients with or without diabetes treated with beta-blockers.
    Bobbio M; Ferrua S; Opasich C; Porcu M; Lucci D; Scherillo M; Tavazzi L; Maggioni AP;
    J Card Fail; 2003 Jun; 9(3):192-202. PubMed ID: 12815569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure.
    De Freitas O; Lenz O; Fornoni A; Materson BJ
    Vasc Health Risk Manag; 2006; 2(2):139-44. PubMed ID: 17319457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of baseline and changes in systolic blood pressure over time on the effectiveness of valsartan in the Valsartan Heart Failure Trial.
    Anand IS; Rector TS; Kuskowski M; Thomas S; Holwerda NJ; Cohn JN
    Circ Heart Fail; 2008 May; 1(1):34-42. PubMed ID: 19808268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Consistency of the beneficial effect of metoprolol succinate extended release across a wide range dose of angiotensin-converting enzyme inhibitors and digitalis.
    Ghali JK; Dunselman P; Waagstein F; Goldstein S; Gottlieb SS; Deedwania PC; Wikstrand JC
    J Card Fail; 2004 Dec; 10(6):452-9. PubMed ID: 15599834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do cardioselective beta-adrenoceptor antagonists reduce mortality in diabetic patients with congestive heart failure?
    Subramanian U; Kamalesh M; Temkit M; Eckert GJ; Sawada S
    Am J Cardiovasc Drugs; 2009; 9(4):231-40. PubMed ID: 19655818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
    Terra SG; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hamilton KK; Aranda JM; Hill JA; Yarandi HN; Walker JR; Phillips MS; Gelfand CA; Johnson JA
    Clin Pharmacol Ther; 2005 Mar; 77(3):127-37. PubMed ID: 15735607
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of carvedilol versus metoprolol CR/XL on mortality in patients with heart failure treated with cardiac resynchronization therapy: a COX multivariate regression analysis.
    Shen X; Nair CK; Aronow WS; Hee T; Esterbrooks DJ
    Am J Ther; 2013; 20(3):247-53. PubMed ID: 21642836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.
    Willenheimer R; van Veldhuisen DJ; Silke B; Erdmann E; Follath F; Krum H; Ponikowski P; Skene A; van de Ven L; Verkenne P; Lechat P;
    Circulation; 2005 Oct; 112(16):2426-35. PubMed ID: 16143696
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sustained restoration of autonomic balance with long- but not short-acting metoprolol in patients with heart failure.
    Aquilante CL; Terra SG; Schofield RS; Pauly DF; Hatton PS; Binkley PF; Johnson JA
    J Card Fail; 2006 Apr; 12(3):171-6. PubMed ID: 16624680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial.
    Dobre D; van Veldhuisen DJ; Mordenti G; Vintila M; Haaijer-Ruskamp FM; Coats AJ; Poole-Wilson PA; Flather MD;
    Am Heart J; 2007 Jul; 154(1):109-15. PubMed ID: 17584562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice.
    Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
    Arch Intern Med; 2008 Dec; 168(22):2415-21. PubMed ID: 19064823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carvedilol versus controlled-release metoprolol for elderly veterans with heart failure.
    Rector TS; Anand IS; Nelson DB; Ensrud KE
    J Am Geriatr Soc; 2008 Jun; 56(6):1021-7. PubMed ID: 18384583
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of beta-blockade on baroreceptor and autonomic function in heart failure.
    Sanderson JE; Yeung LY; Chan S; Tomlinson B; Kay R; Woo KS; Bernardi L
    Clin Sci (Lond); 1999 Feb; 96(2):137-46. PubMed ID: 9918893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysis.
    Bell DS; Lukas MA; Holdbrook FK; Fowler MB
    Curr Med Res Opin; 2006 Feb; 22(2):287-96. PubMed ID: 16466600
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
    Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.